The UK IBD Registry

The IBD Registry is the vehicle for the biologics audit and quality improvement programme. Teams can participate using a choice of data entry systems including existing local systems. Being part of the Registry will give teams:

  • Local data to manage their biologics patients and IBD service more effectively
  • The chance to be part of a national audit of the safety and appropriate use of biologics and biosimilars

The Registry has the potential to become a unique resource for real-world clinical effectiveness and health economic studies in IBD care. While data can be collected on all IBD treatments, the focus for 2016/17 is on biologics. The aims are to:

  • Transfer data collection to the IBD Registry from the RCP biological therapy audit web tool, which has now closed
  • Develop a near-complete UK Register of IBD patients on biologics by the end of 2017

Find out more about…

HOW TO JOIN DATA ENTRY OPTIONS

 

Audit & Registry – where next?

The UK IBD Registry:
an introduction

Driving excellence with the IBD Registry

Save

Save

Save

Save

Save